Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rhodri Harfoot

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Microbiology (Seoul, Korea)|March 1, 2017
H5 influenza, a global updateRhodri Harfoot, Richard J Webby
Pharmaceutics|September 28, 2023
Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 InfectionTushar Saha, Shubhra Sinha, Rhodri Harfoot, et al.
International Journal of Pharmaceutics|September 13, 2023
Inhalable dry powder containing remdesivir and disulfiram: Preparation and in vitro characterizationTushar Saha, Shubhra Sinha, Rhodri Harfoot, et al.
Pharmaceutics|July 27, 2022
Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry PowderTushar Saha, Shubhra Sinha, Rhodri Harfoot, et al.
Biomolecules|November 25, 2023
Neuroproteomic Analysis after SARS-CoV-2 Infection Reveals Overrepresented Neurodegeneration Pathways and Disrupted Metabolic PathwaysIndranil Basak, Rhodri Harfoot, Jennifer E Palmer, et al.
Scientific Reports|December 8, 2017
Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus EndonucleaseDiane Beylkin, Gyanendra Kumar, Wei Zhou, et al.
Viruses|November 27, 2021
Rapid Response to SARS-CoV-2 in Aotearoa New Zealand: Implementation of a Diagnostic Test and Characterization of the First COVID-19 Cases in the South IslandBlair Lawley, Jenny Grant, Rhodri Harfoot, et al.
Pathogens (Basel, Switzerland)|January 21, 2022
Ultraviolet-C Irradiation, Heat, and Storage as Potential Methods of Inactivating SARS-CoV-2 and Bacterial Pathogens on Filtering Facepiece RespiratorsRhodri Harfoot, Deborah B Y Yung, William A Anderson, et al.
Viruses|February 26, 2022
Characterization of the First SARS-CoV-2 Isolates from Aotearoa New Zealand as Part of a Rapid Response to the COVID-19 PandemicRhodri Harfoot, Blair Lawley, Leonor C Hernández, et al.
Cancers|February 5, 2020
Dephosphorylation of YB-1 is Required for Nuclear Localisation During G<sub>2</sub> Phase of the Cell CycleSunali Mehta, Cushla McKinney, Michael Algie, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Microbiology (Seoul, Korea)|March 1, 2017
H5 influenza, a global updateRhodri Harfoot, Richard J Webby
Pharmaceutics|September 28, 2023
Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 InfectionTushar Saha, Shubhra Sinha, Rhodri Harfoot, et al.
International Journal of Pharmaceutics|September 13, 2023
Inhalable dry powder containing remdesivir and disulfiram: Preparation and in vitro characterizationTushar Saha, Shubhra Sinha, Rhodri Harfoot, et al.
Pharmaceutics|July 27, 2022
Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry PowderTushar Saha, Shubhra Sinha, Rhodri Harfoot, et al.
Biomolecules|November 25, 2023
Neuroproteomic Analysis after SARS-CoV-2 Infection Reveals Overrepresented Neurodegeneration Pathways and Disrupted Metabolic PathwaysIndranil Basak, Rhodri Harfoot, Jennifer E Palmer, et al.
Scientific Reports|December 8, 2017
Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus EndonucleaseDiane Beylkin, Gyanendra Kumar, Wei Zhou, et al.
Viruses|November 27, 2021
Rapid Response to SARS-CoV-2 in Aotearoa New Zealand: Implementation of a Diagnostic Test and Characterization of the First COVID-19 Cases in the South IslandBlair Lawley, Jenny Grant, Rhodri Harfoot, et al.
Pathogens (Basel, Switzerland)|January 21, 2022
Ultraviolet-C Irradiation, Heat, and Storage as Potential Methods of Inactivating SARS-CoV-2 and Bacterial Pathogens on Filtering Facepiece RespiratorsRhodri Harfoot, Deborah B Y Yung, William A Anderson, et al.
Viruses|February 26, 2022
Characterization of the First SARS-CoV-2 Isolates from Aotearoa New Zealand as Part of a Rapid Response to the COVID-19 PandemicRhodri Harfoot, Blair Lawley, Leonor C Hernández, et al.
Cancers|February 5, 2020
Dephosphorylation of YB-1 is Required for Nuclear Localisation During G<sub>2</sub> Phase of the Cell CycleSunali Mehta, Cushla McKinney, Michael Algie, et al.
Pageof 2